1. Home
  2. CISS vs BGLC Comparison

CISS vs BGLC Comparison

Compare CISS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C3is Inc.

CISS

C3is Inc.

N/A

Current Price

$1.16

Market Cap

2.7M

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$0.68

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CISS
BGLC
Founded
2022
2017
Country
Greece
Malaysia
Employees
N/A
N/A
Industry
Marine Transportation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.4M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
CISS
BGLC
Price
$1.16
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 371.3K
4.8K
Earning Date
11-18-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.78
EPS
★ N/A
N/A
Revenue
N/A
★ $7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.82
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.06
$0.66
52 Week High
$6.06
$4.97

Technical Indicators

Market Signals
Indicator
CISS
BGLC
Relative Strength Index (RSI) 53.06 24.57
Support Level $0.26 N/A
Resistance Level $1.76 $0.95
Average True Range (ATR) 0.26 0.07
MACD 0.04 -0.01
Stochastic Oscillator 42.27 0.00

Price Performance

Historical Comparison
CISS
BGLC

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including national and private industrial users, commodity producers, and traders. The company owns and operates a fleet of two dry bulk carriers that transport bulk commodities such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: